A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP
A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP

Coronavirus: Antiviral that has ‘shown promise’ among US biomedical agency’s drug tests, after patient responds to remdesivir medication

  • Gilead Sciences’ remdesivir was initially developed to fight the Ebola virus, and the company is working with Chinese health officials on a clinical trial
  • The first coronavirus patient in the United States was treated with remdesivir in late January and his symptoms improved

Topic |   Coronavirus pandemic
A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP
A National Institute of Allergy and Infectious Diseases (NIAID) scientist returns a coronavirus vaccine sample to a freezer in Bethesda, Maryland. Researchers are scrambling to find a treatment for the potentially deadly illness. Photo: NIAID via AP
READ FULL ARTICLE